Plasma kisspeptin levels are also increased in patients with steatosis and MASH, compared to healthy subjects, suggesting that the upregulation of the KISS1R signaling pathway is a compensatory and protective response aiming to resolve MASH [13]. Here, KISS1R is linked to steatosis.